Cancer Synoptic Reporting Project Group
9-January-2023 at 15:30 - 16:30 UTC
Attendees
Scott Campbell Ji-Eun Hwang dubois Laszlo Igali Jim Case @davidkwan @brianrous Daniel Karlsson Nicola Ingram @brianrous Nicola Ingram @rosssimpson Thomas Ruediger @kerenhulkower Raj Dash Suzanne Santamaria Elaine Wooler @ericdaley Keng-Ling Wallin @eric daley Elaine Wooler Unknown User (ebazyleva)
Meeting Recording (GoogleDrive)
Discussion items
| Item | Description | Owner | Notes | Action |
|---|---|---|---|---|
| 1 | Record meeting | Scott Campbell | Cannot do! Not a host Done!! | |
| 2 | Closing gaps in content - dysplasia and neoplasia at margins | Scott Campbell |
|
Observable entity concepts are fine. Jim Case asked for documentation on the *plasias and High-/Low- grading definitions as supporting documentation for ongoing use Scott Campbell will draft a "blurb" and pathologists on the call will provide appropriate citations. 1/9/2023 - HG dysplasia vs. CIS. Discussed the use of HG dysplasia, carcinoma in situ (CIS), and the and/or version. This needs to be reviewed as the and/or for lymphovascular invasion body structure does not look correct for subsumption and classification. GCIs may not be possible as they need defining attributes. RE: #plasias. Thomas Ruediger supports a single set of morphologic abnormality concepts for glandular dysplasia, glandular intraepithelial neoplasia, squamous dysplasia, intraepithelial squamous neoplasia that are completely organ agnostic. @ stefandubois suggests that such a conflation of concepts will require a comprehensive review by organ system. In my opinion, both are correct. This dovetails nicely into the Histology QI project. The CSRWG needs to address what needs to/can be done to get the synoptic reporting content deliverable in the shorter term while also addressing the longer term Histology QI issue. |
| 3 | Missing body structures |
| Not discussedScott Campbell will put lists of concepts needed together for group review via email. Discussions can happen asynchronously | |
| 4 | Wilms tumor/nephroblastoma NICTIZ |
| Scott Campbell to follow up. Paul Seegers forwarded protocolSIOP-F4.pdf Scott Campbell meeting with Nictiz on Friday, 1/16/23 | |
| 5 | GU histologies |
| @stefan dubois; @brian rous; @ross simpson will assist. Scott Campbell will get meetings started. | |
| 6 | Follow up on protocol review by authoritative bodies | Scott Campbell |
| Scott Campbell will forward marked up ICCR, RCPath protocols to team for review of SNOMED CT content bindings.
Needs to be followed up in another meeting. |
| 8 | Business meeting |
| 2 > half days; Also pathology CRG will meet f2f |
Meeting Files
| Attachments |
|---|
Previous Meetings
| Content Report Table | ||||||||
|---|---|---|---|---|---|---|---|---|
|